Image-Guided Stereotactic Radiosurgery (SRS) Boost for HPV-Oropharyngeal Cancer

NACompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

March 1, 2010

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
Cancer of the Oropharynx
Interventions
RADIATION

Stereotactic Radiosurgery

Patients will receive 6 weeks of IMRT (standard of care) followed by the stereotactic radiosurgery (SRS Boost). Dose of the boost is reliant on which cohort the patient is assigned to. Cohort 1 will receive 8 Gy, Cohort 2 will receive 10 Gy in a single fraction, Cohort 3 will receive 10 Gy split into two fractions.

Trial Locations (1)

11042

Northwell Health- Center for Advanced Medicine, Lake Success

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Northwell Health

OTHER

NCT02703493 - Image-Guided Stereotactic Radiosurgery (SRS) Boost for HPV-Oropharyngeal Cancer | Biotech Hunter | Biotech Hunter